Background: Chronic Obstructive Pulmonary Disease (COPD) treatment includes a multidisciplinary approach, with physiotherapy a prominent role that promotes a positive impact on the quality of life (QOL) of these patients. Objective: To analyze the effects of physiotherapeutic interventions on QOL, lung volumes and capacities, and respiratory muscle strength in COPD patients. Methods: 17 subjects participated in the study, randomly divided into 2 groups: 1) Maneuvers: 62.7 ± 15.4 years, 1.65 ± 0.12 m, 81.4 ± 18.2 kg, body Mass Index (BMI) 29.9± 5.0 kg/m
INTRODUCTION
Chronic Obstructive Pulmonary Disease (COPD) is considered a worldwide public health problem, characterized by chronic and progressive obstruction of the airflow, partially reversible, leading to high morbidity and mortality, especially in older adults (1, 2) . In Brazil, there are about 7.5 million people afflicted with COPD, being considered the seventh cause of mortality with more than 37,000 deaths per year, bringing an annual public cost of approximately R$100 million, as 70% of subjects depend on the Unified National Health System (SUS) for treatment (3) . Destruction of the pulmonary parenchyma caused by COPD causes loss of alveolar connections of the small airways and a decrease in pulmonary elasticity, making it difficult to open these pathways during expiration, leading to an increase in functional residual capacity (FRC) and a decrease in inspiratory capacity (IC), resulting in pulmonary hyperinflation (4) (5) (6) and reduced tolerance to physical exertion (7) . Pulmonary hyperinflation alters the shape and geometry of the thoracic wall, resulting in chronic reduction of the diaphragm apposition zone, decreasing the muscle's capacity to generate force, thereby increasing mechanical workload and airflow limitation, leading to weakness and a decrease in inspiratory muscle strength associated with reduced diaphragmatic yield (5, 8) . Spirometry is one of the best methods to measure changes in respiratory mechanics caused by COPD, and can be used in both the diagnosis and evaluation of pulmonary function. It is possible to obtain dynamic pulmonary volume values via spirometry (9) which provide essential information for characterizing the pathophysiological state of the lungs (10) . As spirometry is defined as the measurement of volumes and airflows, especially Vital Capacity (VC), Forced Expiratory Volume in the first second (FEV 1 ) and Forced Vital Capacity (FVC), in addition to the correlations between these, its evaluation becomes essential in the diagnosis and treatment of individuals with airflow restriction (11, 12) . Abnormal spirometry is an important prognosis in patients with COPD, since a progressive decrease in FEV 1 is indicative of their survival. In addition, respiratory muscle weakness is related to VC, where a decrease of respiratory muscle determines a reduction of more than 50% of the normal force of these muscles (12) . In addition, manovacuometry is also an indispensable method to evaluate inspiratory muscle strength (maximum inspiratory pressure -MIP) and expiratory muscles (maximal expiratory pressure -MEP), being considered an important tool of respiratory physical therapy (13) . It is known today that minimizing complications resulting from pulmonary functional loss through respiratory exercises increases pulmonary ventilation and gas exchange efficiency, thus improving the contraction efficiency of respiratory muscles, reducing the sensation of dyspnea and energy expenditure during ventilation, and the individual can perform their activities of daily living (ADL) without major disruption to the body (14) (15) (16) . Therefore, COPD treatment includes a multidisciplinary approach which takes into account aerobic and inspiratory muscle training, as well as behavioral instructions (14) (15) (16) (17) , in addition to physiotherapy having a prominent role, since its treatment has a positive impact on the quality of life of these individuals (17) . Currently, there is consensus in the rehabilitation of these patients to improve aerobic capacity, which may be associated with other techniques such as respiratory muscle resistive training (18, 19) , however, the lack of elucidation of these protocols (20) and the few studies that specifically evaluate thoracic muscle changes (18) make this study interesting. Based on this, it is hypothesized that there is improvement in respiratory muscle strength and lung function after the rehabilitation program, accompanied by an increase in the quality of life (QOL) of these patients. Thus, the objective of the present study was to compare the effects of two physiotherapeutic intervention programs on QOL, lung volumes and capacities, and respiratory muscle strength in COPD patients.
METHODS

Sample characterization
Initially, the sample consisted of 23 subjects; however, only 17 patients completed the study and were randomly divided into 2 groups (Maneuvers and Threshold). The "Maneuvers" group consisted of 7 patients (5 males and 2 females: 62.7 ± 15.4 years, 1.65 ± 0.12 m, 81.4 ± 18.2 kg and body mass index (BMI): 29.9 ± 5.0 kg/m 2 ) and the "Threshold" group had 10 subjects (4 males and 6 females: 64.4 ± 11.2 years, 1.58 ± 0.08 m, 70.7 ± 9.4 kg and BMI: 28.6 ± 3.7 kg/m 2 ). Six patients from the maneuvers group declined to participate in the study for the following reasons: 2 subjects did not meet the inclusion criteria; and 4 abandoned treatment ( Figure 1 ).
All subjects who participated in the study met the following inclusion criteria: 1) have a proven diagnosis (clinical and imaging examination) of COPD; and 2) do not present any neurological, cardiovascular or musculoskeletal problems; in addition to loss of cognitive ability, which would have made it impossible to carry out the evaluation and/or the treatment program. For the sample calculation, G*Power 3.1.0 software was used and the procedures followed the recommendations of Beck (21) . A power of 0.95 was adopted a priori considering a significance level of 5% and an effect size of 0.8, therefore a total 'n' of 23 subjects was calculated; however, due to sample loss the calculation was scaled to a power of 0.8, a significance level of 5%, and an effect size of 0.75, so that a total 'n' of 16 subjects was recalculated. This analysis was performed to reduce the probability of type II error and to determine the minimum number of individuals required for this investigation. Thus, the sample size was sufficient to provide 80% statistical power. All patients who agreed to participate were instructed on the risks and benefits of the study and signed the clear and 
Procedures
QOL was initially assessed by the Saint George Hospital Respiratory Disease (SGHRQ) self-administered questionnaire, validated and translated into Portuguese by Sousa et al. (22) ,
Figure 1. Sample Flow Diagram
MTP&RehabJournal 2018, 16: 625 which allows comparing health status among populations of patients and quantify changes in health after therapy. It is divided into three domains (symptoms, activities and psychosocial impacts) for which the respiratory disease inflicts the individual, having a maximum score for each domain where the sum of these results in a score of 0 to 100%, and the higher the percentage, the worse the quality of life is. Spirometry was performed using a digital pneumonograph (Pneumotach Datalink, France) in a room with a temperature of approximately 20°C (23) , in which the patients rested for 5 to 10 minutes before the test. They were then instructed to remain in the seated position, using the nasal clip and with their head held in a neutral position ( Figure 2B ), so as not to change the initial forced expiratory flows by varying the tracheal stiffness and without using bronchodilators (22) . In order to measure VC, the patient had an inspiration until total lung capacity (TLC) and expired without interruption until the residual volume (RV) was reached. Then the patient was also asked to expire as fast and intensely as possible after an inspiration to the TLC in order to verify FVC. The test consisted of 3 consecutive repetitions for each maneuver, with an interval of 1 minute between them, and the VC was validated when the difference between at least two maneuvers was less than 0.10 l, and the maneuver was repeated if this difference was not obtained. The two largest values should differ less than 0.15 l for validating FVC and FEV 1 , with the highest values of VC, FVC and FEV 1 being selected, according to Pereira (12) . I n eva l u at i n g re s p i rato r y m u s c l e st re n gt h , a manovacuometer (CriticalMed -Brazil) was used to verify MIP and MEP. To measure MIP, the subject was instructed to exhale to the RV and then inhale up to the TLC, while they were also instructed to inhale up to the TLC and then exhale until the RV in order to gauge the MEP (13) . Three attempts were made for each respiratory pressure with a duration of at least 2 seconds and a 1-minute interval between them, with highest value being considered for analysis (Figure 2A ).
Intervention
The acceleration -EFA); functional respiratory re-education by means of diaphragmatic respiration and pursed-lip breathing, (20, 24) and aerobic training on the treadmill for 20 minutes with a workload of 70% maximum heart rate (HR) (HR max = 220-age), with 2.5 minutes of warmup and 2.5 minutes of cool-down ( Figures 2C, D and E) . Moreover, the "Threshold" group performed 10 minutes of stretching the muscles of the upper and lower limbs; 15 minutes of upper and lower rib pompage, as well as sternocleidomastoid (SCM) and anterior scalene (AS) muscle pompage; 10 minutes of inspiratory muscle training using the Threshold (Respiron -NCS, Brazil) at 40% MIP obtained in the first session of each week; and aerobic training on the treadmill for 20 minutes with a workload of 70% maximum heart rate (HR max = 220-age), with 2.5 minutes of warm-up and 2.5 minutes of cool-down ( Figure 2C, D and AND) .
Data analysis
The Statistical Package for the Social Sciences (SPSS -20.0, Armonk, USA)) software program was used for the statistical procedures. First, normality tests (Shapiro-Wilk) were performed, followed by Student's t-test (paired) and Wilcoxon test for pre and post-intervention comparisons of SGRQ domains and total score, VC, FVC, FEV 1 , MIP and MEP, and Student's t-test (independent) and Mann-Whitney in the intergroup comparison, considering a significance level of 5% for all analyzes. In comparing the anthropometric variables, the intra-class correlation test (ICC) was used according to the following classification: null = 0.0; weak = 0.01 to 0.3; regular = 0.31 to 0.6; strong = 0.61 to 0.9; very strong = 0.91 to 0.99; and full = 1.0. 
RESULTS
The ICC showed very strong (r = 0.91 to 0.99) and significant (P < 0.001) correlations between the groups (Maneuvers X Threshold) for the anthropometric variables: Age (r = 0.951, P < 0.001); Height (r = 0.958, P < 0.001) and BMI (r = 0.902, P < 0.006); and strong (r = 0.61 to 0.9) for Body Mass (r = 0.758, P < 0.048), according to Araújo et al. (25) . According to Table 1 , there was a significant difference for both the "Maneuvers" group (Symptoms: P = 0.003; Activities: P = 0.021; Psychosocial Impact: P = 0.018; Total: P = 0.002) and for the "Threshold" group (Symptoms: P = 0.017; Activities: P = 0.012; Psychosocial Impact: P = 0.003; and Total: P = 0.001) in comparing the SGRQ pre and post intervention values in the 3 domains and in the total score. As can be seen in Table 2 , there was no significant difference (P > 0.05) in the comparison between the intergroup SGRQ domain values (Maneuvers x Threshold) in both the pre-and post-intervention physiotherapy.
For spirometry (VC, FVC, and FEV 1 ), there was no significant difference in any of the analyzed variables for the "Maneuvers" group (VC: P = 0.099; FVC: P = 0.871; and FEV 1 : P = 0.288), or for the "Threshold" group (FVC: P = 0.386, VC: P = 0.455, and FEV 1 : P = 0.117). However, there was a significant difference in relation to manovacuometry (MIP and MEP) in the comparison of pre and post-intervention values, both in the "Maneuvers" group (MIP: P = 0.028, MEP: P = 0.046) and in the "Threshold" group (MIP: P = 0.028, MEP: P = 0.028), as can be seen in Table 3 . There were no significant differences (P> 0.05) in the intergroup comparison (Maneuvers x Threshold) either pre-or post-intervention (Table 4) in all the analyzed variables: spirometry (VC, FVC and FEV 1 ) and manovacuometry (MIP and MEP). 
DISCUSSION
The main findings in the present study generally showed an exponential improvement in QOL quantified in all SGHRQ domains and manovacuometry data (MIP and MEP) of patients with COPD in the 2 analyzed protocols (Maneuvers and Threshold). The post-intervention SGHRQ values in all domains point to an improvement in the QOL of these subjects, thus suggesting that both protocols have positively provided recovery in these patients, since according to Teixeira et al. (26) , estimating the QOL enables quantifying the degree of influence the disease has on the lives of these patients, since this is a way to evaluate their response to treatment. The results of the present study corroborate those found by Paulin et al. (18) , who underwent a 8-week pulmonary rehabilitation program; and Teixeira et al. (26) who submitted patients to upper and lower limb strengthening exercises with aerobic training on a treadmill for 12 weeks, where both studies showed a reduction in the values of the 3 domains and in the total score of the SGRQ post-physiotherapeutic intervention. In this sense, Furlanetto et al. (27) compared 104 active and inactive subjects with COPD using a biaxial accelerometer combined with physiological sensors SenserWear Armband -SWA (BodyMedia Inc., Pittsburgh, PA), who observed that physically active subjects had better aerobic capacity and pulmonary function compared to inactive subjects. Regarding the spirometric evaluation, it was verified that there was no improvement in the pulmonary function of VC, FVC and FEV 1 variables, which shows that there was no change in the airway obstruction level. This corroborates the study by O'Donnell et al. (28) , who also did not find significant improvements in spirometry after intervention after analyzing 20 COPD patients who underwent a physical therapy intervention protocol consisting of physical and respiratory exercise sessions for 6 weeks. Likewise, Jamami et al. (29) also did not find a significant difference in pulmonary function in analyzing 22 subjects who underwent physical activities, inspiratory muscle training and respiratory re-education for 6 weeks (2 times/week).
A possible explanation for the fact that spirometry data remained unchanged was reported by Tiep (30) when describing that pulmonary function tests, especially spirometry, describe the current state of the physiological dysfunction, but it is not able to define the benefits of the rehabilitation program when compared to the well-being referred by the patient. Along these lines, Lopes et al. (31) affirm that repeating spirometry in less than a 1-year interval in stable patients is not useful for comparing post-intervention effects; however, this evaluation should be performed if there is significant worsening of symptoms or some complication in these patients. This fact is confirmed in the study by Paulin et al. (18) and Rodrigues et al. (32) , in which they affirm that rehabilitation programs did not show changes in pulmonary function after aerobic physical conditioning, but in the secondary damage from COPD.
Regarding manovacuometry, the results showed that there was a significant improvement of MEP and MIP. This corroborates the study by Kunikoshita et al. (20) , who observed a significant increase in MIP in 25 patients with COPD after 6 weeks of aerobic training associated with strengthening the inspiratory musculature; and that of Trevisan et al. (33) who affirmed that respiratory muscle training provided improvement in the strength of these muscles and an increase in MIP and MEP with 19 subjects affected by COPD who had undergone 8 weeks of inspiratory muscle strengthening as well as abdominal and quadriceps muscle strengthening exercises, despite not having used aerobic training as in the present study. This is confirmed by Ramírez-Sarmiento et al. (34) in performing a study of 14 COPD patients who underwent inspiratory muscle training or simulated training with no pressure load for 5 weeks (30 minutes; 5 days a week), showing that respiratory muscle training improved inspiratory muscle strength and endurance, and they observed adaptive changes in the proportion of type I fibers and type II muscle fibers in subjects submitted to inspiratory muscle training. Regarding MEP, the present study corroborates that of Di Lorenzo et al. (35) , which showed that the increase in MEP is due to the fact that the mechanical efficiency of the expiratory muscles is better, since an increase in the inspiratory force provides better performance of these muscles.
A limitation of this study is the low number of subjects due to the difficulty of recruiting them in the study, since these patients rarely seek and/or are referred for specific physiotherapeutic care, making it difficult to participate in the research, thus constituting a factor that may have influenced the results presented herein. There is still the fact that the protocol consists of 30 sessions, 3 times a week, which demands availability and transportation/commuting costs of these patients.
CONCLUSIONS
The results of the present study showed that the proposed physiotherapeutic protocols promoted improvement in QOL and MIP and MEP muscle strength in all COPD patients, regardless of the group (Maneuvers or Threshold) to which they were allocated, behaving in a similar way in all analyzed variables, and thereby largely confirming the hypothesis of this study. Despite the low sample size, the exponential improvement in QOL, the gain in MIP and MEP, and the low cost of the proposed physiotherapeutic interventions all lead to suggest implementing these protocols in public health services in order to attend patients with COPD.
